Skip to content
  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
Daily News India

Daily News India

Just another WordPress site

  • English
  • Business
  • Entertainment
  • National
  • Lifestyle
  • Education
  • Toggle search form
  • Connplex Cinemas Expands Nationwide Footprint with New Openings in Odisha and Maharashtra Business
  • Cosmetico Labs introduce India’s first ‘Beauty Incubator’ Business
  • On This ‘WORLD CANCER DAY’: 8 Best Oncologists Share Their Advice on Increasing Risks of Cancer Business
  • A New Talk of The Town Business
  • From 35 Years of Racing to Dakar 2026: The Journey of aerpace Racer Sanjay Takale Sports
  • Launch of Global Participation Campaign for Operation Blue Freedom – Water World Record at Lakshadweep Islands Press Release
  • Zero Cost Inbound Marketing is the flavor of 2025 and beyond, says Mahima Bhatia, Founder Brand To Bytes Business
  • Corporate Professionals managing to acquire 26% stake in Advik Capital for Rs 23.75 cr Business

Dr. Yukata Niihara felicitated by Honourable Minister of State, Shri Arun Halder for developing FDA- approved drug ENDARI to fight SCD

Posted on December 16, 2022 By

Dr. Yukata Niihara was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable  Minister of State, Shri Arun Halder

New Delhi, December 16: Dr. Yukata Niihara, e CEO and Chair of Emmaus life sciences Inc. USA, an internationally renowned doctor with over a dozen awards and citations, was felicitated in an event held at the World Trade Center, Cuffe Parade by the Honourable Minister of State, Shri Arun Halder. This felicitation came as a recognition of Dr. Yuktaka Niihara’s work – the development of an FDA-approved drug ENDARI to fight the scrounge of Sickle cell syndrome worldwide. The event was hosted by Dr.Aditi Govatrikar, a famous Bollywood personality, and Miss World.

Over 20 million people in India suffer from sickle cell disease (SCD) due to genetic reasons. Tribal communities, in particular, are affected at a disproportionately high percentage and suffer exorbitantly because of being underprivileged and lack of resources. To ameliorate their condition and save hundreds of lives, it is vitally necessary to introduce this medication in India.

Dr.Niihara has tied up with an Indian Mumbai-based company, Akash Biomatrix Pvt. Ltd. represented by the undersigned to market and distribute this medicine in India at affordable prices. Emmaus Life sciences Inc of the USA is also seriously exploring setting up a manufacturing and Biotech research facility in India with an initial investment of over USD 300 million.

If you have any objection to this press release content, kindly contact pr.error.rectification[at]gmail.com to notify us. We will respond and rectify the situation in the next 24 hours

Health Tags:Healthcare

Post navigation

Previous Post: What Makes Honey the Most Natural Superfood and What Are Its Benefits?
Next Post: Gali Guleiyan: In the Shadows with Manoj Bajpai

Related Posts

  • MGL Aarogya Programme Empowers 2,000 Rural Women in Raigad with Cervical Cancer Awareness and Screening Health
  • Sterling Hospitals’ Sindhubhavan Unit Spearheads Major Cancer Awareness Walkathon with Rotary Club Health
  • AI Progress in Healthcare: How Intelligent Technology Is Transforming Patient Care Health
  • Sunpure receives the patent for Curcuminoids Complex AKTIV C5 (CURCUBOOST®) Health
  • Asveda: the Ayurvedic brand shields your health with its natural immunity boosters A
  • India Unveils ‘Raktsetu’, Its First-Ever Blood Donation App, During Historic Drive Led by Astro Parduman Health

Recent Posts

  • Lagnam Spintex Reports Strong Q2 & H1 Fy27 Performance; Ebitda Rises 98% In Q2 And 64% In H1fy27
  • PATHVIK Launches to End Career Guesswork: Students Can Now Experience a Career Before They Choose It
  • Celebrating 20 Years of Pioneering India’s Solar Revolution: Orb Energy’s Journey
  • As India’s Top Law Firms Embrace AI, VakilPlus Wants to Bring It to Every Lawyer
  • Onward Technologies Delivers its Strongest-Ever Quarter; Total Revenue up 22.2% and EBITDA up 33.7% YoY; Raises FY27 Outlook

Recent Comments

  • Unknown on Participants Reap Rewards in Wellman’s 8-Week Digital Campaign: IPL Tickets, Autographed Virat Kohli Merchandise, and More!
  • Dr. Pratul Jain Shapes Orthopedic Care through Innovation and Compassion Health
  • Kaushalya Logistics Adds New Marquee Client JSW Cement, with Addition of Four New Depots in Haryana Business
  • Numen Rising, founded by Madhurima Nigam, brings IMMERSIV, The Floating Breathwork Experience to India for the first time, facilitated by Ashley Edelman Lifestyle
  • PAVRA ENTERTAINMENT’s Hindi Feature-Film “Wings Of Freedom” Receives Award On 12th Dada Saheb Film Festival-22 Entertainment
  • Atandra’s KRYKARD Showcases Next-Gen Thermal Imaging Portfolio at IREE 2025 Business
  • The Announcement of Year by All Home Living: Zero Cost EMI for all AV Lovers Lifestyle
  • Emerge Renewables Marks a Historic Milestone with Furnace Light-Up of North India’s First Dedicated Solar Glass Manufacturing Plant Business
  • Student Circus and ZigMe Conclude Talent Connect—UK–India 2026, Advancing India’s Role as a Strategic Career Market for Globally Educated Indian Graduates Business

Copyright © 2026 Daily News India.

Powered by PressBook News WordPress theme